Alpine Immune Sciences Inc

NASDAQ:ALPN   3:59:53 PM EDT
11.67
+0.77 (+7.06%)
Earnings Announcements

Alpine Immune Sciences Posts Q3 Loss Per Share Of $0.55

Published: 11/10/2021 21:56 GMT
Alpine Immune Sciences Inc (ALPN) - Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2021 Financial Results.
Alpine Immune Sciences - Expects That Its Current Cash Resources Are Sufficient to Fund Alpine's Planned Operations Through 2023.
Alpine Immune Sciences - Qtrly Loss per Share $0.55.
Revenue is expected to be $13.97 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $12.08 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.